Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Francois H Geschwind

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Clinical Advances in Hematology & Oncology : H&O|April 9, 2016
Locoregional therapy for patients with hepatocellular carcinomaJean-Francois H Geschwind
Gastroenterology & Hepatology|June 23, 2016
Locoregional Therapy for Patients With Hepatocellular CarcinomaJean-Francois H Geschwind
Journal of Vascular and Interventional Radiology : JVIR|October 25, 2002
Chemoembolization for hepatocellular carcinoma: where does the truth lie?Jean-Francois H Geschwind
Cancer Journal (Sudbury, Mass.)|April 21, 2010
Chemoembolization for primary and metastatic liver cancerEleni Liapi, Jean-Francois H Geschwind
Seminars in Oncology|May 25, 2010
Locoregional intra-arterial therapies for unresectable intrahepatic cholangiocarcinomaKelvin Hong, Jean-Francois H Geschwind
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2007
Transcatheter and ablative therapeutic approaches for solid malignanciesEleni Liapi, Jean-Francois H Geschwind
Clinical Advances in Hematology & Oncology : H&O|August 4, 2016
Sorafenib in combination with transarterial chemoembolization for the treatment of hepatocellular carcinomaJean-Francois H Geschwind, Julius Chapiro
Cardiovascular and Interventional Radiology|June 13, 2020
Predicting Patient Survival in Oncology: Is it Time to Take a New Path?Nariman Nezami, Jean-Francois H Geschwind
Clinical Liver Disease|June 13, 2019
Novel local therapies in hepatocellular carcinomaEleni Liapi, Jean-Francois H Geschwind
Annals of Surgical Oncology|March 25, 2011
Medium-sized HCC: achieving effective local tumor control with combined chemoebolization and radiofrequency ablationEleni Liapi, Jean-Francois H Geschwind
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Clinical Advances in Hematology & Oncology : H&O|April 9, 2016
Locoregional therapy for patients with hepatocellular carcinomaJean-Francois H Geschwind
Gastroenterology & Hepatology|June 23, 2016
Locoregional Therapy for Patients With Hepatocellular CarcinomaJean-Francois H Geschwind
Journal of Vascular and Interventional Radiology : JVIR|October 25, 2002
Chemoembolization for hepatocellular carcinoma: where does the truth lie?Jean-Francois H Geschwind
Cancer Journal (Sudbury, Mass.)|April 21, 2010
Chemoembolization for primary and metastatic liver cancerEleni Liapi, Jean-Francois H Geschwind
Seminars in Oncology|May 25, 2010
Locoregional intra-arterial therapies for unresectable intrahepatic cholangiocarcinomaKelvin Hong, Jean-Francois H Geschwind
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2007
Transcatheter and ablative therapeutic approaches for solid malignanciesEleni Liapi, Jean-Francois H Geschwind
Clinical Advances in Hematology & Oncology : H&O|August 4, 2016
Sorafenib in combination with transarterial chemoembolization for the treatment of hepatocellular carcinomaJean-Francois H Geschwind, Julius Chapiro
Cardiovascular and Interventional Radiology|June 13, 2020
Predicting Patient Survival in Oncology: Is it Time to Take a New Path?Nariman Nezami, Jean-Francois H Geschwind
Clinical Liver Disease|June 13, 2019
Novel local therapies in hepatocellular carcinomaEleni Liapi, Jean-Francois H Geschwind
Annals of Surgical Oncology|March 25, 2011
Medium-sized HCC: achieving effective local tumor control with combined chemoebolization and radiofrequency ablationEleni Liapi, Jean-Francois H Geschwind
Pageof 12